Results 171 to 180 of about 59,251 (307)

Induction of ischaemic cardiomyopathy in mice without off‐target effects

Experimental Physiology, EarlyView.
Mark T. Waddingham, James T. Pearson
wiley   +1 more source

Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control

, 2022
Karishma Mahtani, Brihitejas Patel, Brian Wang, Anthony Barron   +3 more
openalex   +1 more source

Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol–valsartan and nebivolol–lisinopril polytherapy in SHR rats [PDF]

Diego Lezama‐Martínez, Jazmín Flores‐Monroy, Diana Ramírez‐Hernández, G. Farina, Salvador Fonseca-Coronado, María Elena Hernández‐Campos   +5 more
openalex   +1 more source

High-Performance Liquid Chromatographic and First Derivative of the Ratio Spectrophotometric Determination of Amlodipine and Valsartan in Their Binary Mixtures [PDF]

, 2010
Dilek Kul, Burcu Dogan‐Topal, Tugba Kutucu, Bengi Uslu, Síbel A. Özkan   +4 more
openalex   +1 more source

Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? [PDF]

, 2001
McMurray, John J.V.
core   +1 more source

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV) [PDF]

, 2022
Mingyu Kong, Jon Suh, Inki Moon, Kyung‐Yil Lee, Ho‐Jun Jang, J S Kim, Ik Jun Choi   +6 more
openalex   +1 more source

Correction to ‘Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting’

ESC Heart Failure, Volume 12, Issue 2, Page 1525-1525, April 2025.
wiley   +1 more source

Devastating Worsening Renal Function Following the Initiation of Sacubitril/Valsartan: Falling Between Two Stools [PDF]

, 2023
Akinori Sairaku, Yukiko Nakano
openalex   +1 more source

Effects of LCZ696 (Sacubitril/Valsartan) on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials [PDF]

, 2020
Qiang Geng, Rong-Qiang Yan, Zhengzhong Wang, Fangjie Hou   +3 more
openalex   +1 more source

The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectiveness

, 2021
Huai-Wen Liang, Chia‐Te Liao, Wen-Yu Lin, Fa‐Po Chung, Jin‐Long Huang, Ying‐Hsiang Lee, Po-Lin Lin, Wei‐Ru Chiou, Chien‐Yi Hsu, Hung‐Yu Chang   +9 more
openalex   +1 more source